Menu Search
Equities

Molina Healthcare Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
MHG:MUN

Molina Healthcare Inc

Actions
  • Price (EUR)114.10
  • Today's Change0.35 / 0.31%
  • Shares traded15.00
  • 1 Year change-56.62%
  • Beta0.5479
Data delayed at least 15 minutes, as of Feb 18 2026 07:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Molina Healthcare Inc had net income fall -59.97% from 1.18bn to 472.00m despite a 11.75% increase in revenues from 40.65bn to 45.43bn. An increase in the cost of goods sold as a percentage of sales from 84.69% to 86.93% was a component in the falling net income despite rising revenues.
Gross margin13.07%
Net profit margin1.04%
Operating margin1.72%
Return on assets3.03%
Return on equity11.02%
Return on investment5.93%
More ▼

Cash flow in USDView more

In 2025, cash reserves at Molina Healthcare Inc fell by 393.00m. However, Cash Flow from Investing totalled 312.00m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 535.00m for operations while cash used for financing totalled 170.00m.
Cash flow per share12.60
Price/Cash flow per share10.48
Book value per share79.78
Tangible book value per share36.75
More ▼

Balance sheet in USDView more

Molina Healthcare Inc has a Debt to Total Capital ratio of 49.26%, a lower figure than the previous year's 69.35%.
Current ratio1.69
Quick ratio--
Total debt/total equity0.9708
Total debt/total capital0.4926
More ▼

Growth rates in USD

SmartText is unavailable
EPS growth(5 years)-4.47
EPS (TTM) vs
TTM 1 year ago		-58.21
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.